Market revenue in 2020 | USD 6,449.2 million |
Market revenue in 2028 | USD 10,298.1 million |
Growth rate | 6% (CAGR from 2020 to 2028) |
Largest segment | Mental health |
Fastest growing segment | Neurodegenerative Diseases |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer |
Key market players worldwide | Biogen Inc, Otsuka Pharmaceutical, Eli Lilly and Co, Merck & Co Inc, AstraZeneca PLC, Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.
Mental health was the largest segment with a revenue share of 44.53% in 2020. Horizon Databook has segmented the Germany central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2028.
Germany is the one of the major markets for CNS therapeutics in the Europe region, such as depression, with women being affected almost three times higher than men, as reported by German Depression Foundation.
Several initiatives are being launched by the German government to effectively deal with this growing problem. For instance, the German government adopted the National Dementia Strategy in July 2020 in collaboration with German Alzheimer Society.
The strategy is expected to provide comprehensive solution to support patients and advance health as well as long-term care services for people affected by dementia, along with promoting excellence in research for the condition.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany central nervous system therapeutic market , including forecasts for subscribers. This country databook contains high-level insights into Germany central nervous system therapeutic market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account